•MAZE Surgery
•Catheter Ablation
•Electric Cardioversion
•Pharmacological
On the basis of device type, the market is segmented into:
•Catheter Ablation Devices
•Mapping and Recording Systems
•Access Devices
•Cardiac Monitors
•Intracardiac Echocardiography (ICE) Systems
•Left Atrial Appendage (LAA) and Closure Devices
Rising prevalence of atrial fibrillation, especially among the geriatric population to drive
growth of the atrial fibrillation market
AF increases the life expectancy of a patient, thus the demand for atrial fibrillation is increasing for
treatment of the geriatric population. Growing adoption of catheter ablation and advancements in
technology are expected to fuel growth of the market for atrial fibrillation. However, lack of skilled
professionals and alternative options over AF healing devices are projected to hamper growth of the
atrial fibrillation market. According to the National Center for Biotechnology Information
(NCBI), the prevalence of AF is estimated to double in a span of two decades (2010–2030). Several
government initiatives are working towards making AF more accessible to the general populace.
For instance, favorable regulatory steps such as ‘National Programme for Prevention and Control of
Diabetes, Cardiovascular Diseases and Stroke (NPDCS)’ undertaken by the Government of India,
which aims to prevent and control premature mortality and morbidity from cardiovascular diseases,
stroke, and diabetes mellitus. This I turn, is expected to propel growth of the market during the
forecast period.
North America holds a dominant position in the market, accounting for the largest market share.
The dominance of the market in the region is attributed to high presence of advanced healthcare
facilities and higher adoption of technologically advanced devices and treatment measures such as
AF in countries such as U.S. and Canada, in the region. The market in Asia Pacific is projected to
witness substantial growth in the near future, owing to the growing population in the region and
rapidly aging population, who are highly vulnerable to heart diseases. Also, demand for atrial
fibrillation treatment devices is estimated to increase, owing to the advancements in healthcare
infrastructure and rise in expenditure in the emerging economies such as China and India thereby,
fueling market growth over the forecast period.
Key Players:
Some of the major companies operating in the atrial fibrillation market are
• Cardiofocus, Inc.,
• Biosense Webster Inc.,
• Biotitic Se & Co. Kg,
• St. Jude Medical Inc.,